Lyka Raises $67M in Series C Led by LGVP

Why It Matters

The raise underscores strong investor confidence in the premium pet‑food segment and positions Lyka to shape future standards for data‑driven canine nutrition and longevity research.

Key Takeaways

• $67M Series C led by LGVP
• ARR reaches $200M, 100k dogs served
• Expanding globally, targeting new product categories
• Funding clinical trials on canine longevity
• B Corp, carbon‑negative differentiators

Pulse Analysis

The pet‑food industry is undergoing a premiumization wave, with Australian owners alone spending over $21 billion annually on their animals. Fresh, nutritionally tailored meals like Lyka’s address growing consumer demand for health‑focused products, while the subscription model provides predictable revenue and valuable data streams. By controlling recipe development, manufacturing, and distribution, Lyka leverages technology to personalize portions and dietary profiles, creating a competitive edge over traditional kibble manufacturers.

Lyka’s $67 million Series C injection signals robust confidence from U.S. investors in a market traditionally dominated by legacy brands. The capital will underwrite overseas rollout, requiring localized refrigerated production facilities or strategic supply‑chain partnerships to manage the capital‑intensive nature of fresh‑food logistics. Scaling the model also opens cross‑selling opportunities into treats, supplements, and veterinary‑grade nutrition, potentially expanding the addressable market beyond its current Australian base.

Beyond growth, Lyka’s commitment to peer‑reviewed clinical trials with universities positions the company at the nexus of nutrition science and pet longevity. Results could validate health claims, driving premium pricing and influencing industry standards. Coupled with its B‑Corp certification and carbon‑negative status, Lyka appeals to environmentally conscious consumers, reinforcing brand loyalty. If the research demonstrates measurable lifespan extensions, Lyka may set a new benchmark for data‑driven, sustainable pet care, prompting competitors to invest in similar scientific initiatives.

Deal Summary

Australian fresh dog food subscription startup Lyka announced a $67 million Series C funding round led by New York‑based VC firm LGVP, with participation from other US investors. The capital will fund global expansion, clinical research into canine health, and new product categories. Lyka, founded by Anna Podolsky, reported $200 million ARR and serves over 100,000 dogs.